SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Seattle Genetics, Inc. and Agensys, Inc., an Affiliate of Astellas Pharma Inc., Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer